METHODS AND COMPOSITIONS FOR TREATING BILIARY CHOLESTEROL CRYSTALLIZATION AND RELATED CONDITIONS

摘要

The present invention is directed to the field of treating conditions related to biliary cholesterol crystallization, particularly to the administration of inhibitors of Stearoyl Coenzyme A Desaturase 1, wherein the inhibitor of SCD1 enzymatic activity is not a fatty acid bile acid conjugate (FABAC).